Website Changes
10/28/2005
~~~Sharing Hope~~~ A Brain Tumor Meeting
For Patients/Survivors and Families
10/28/2005
Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury.
10/28/2005
Immunohistochemical Analysis of Platelet-derived Growth Factor Receptor-alpha, -beta, c-kit, c-abl, and arg Proteins in Glioblastoma: Possible Implications for Patient Selection for Imatinib Mesylate (Gleevec) Therapy.
10/28/2005
CereproTM Marketing Authorisation Application Review Commences in Europe
10/27/2005
`CUTS FOR CURES` fundraiser in Hatboro, PA
10/26/2005
Free Caregiver Workshop -
For friends, partners and/or family members
of a person living with a brain tumor
10/26/2005
New approach to chemo: Continuous, lower doses
10/26/2005
FDA Approves Brain Stem Cell Transplant and Genentech Inks Another Brain Cancer Deal
10/26/2005
Oncolytics Biotech Inc. Announces 2005 Third Quarter Results
10/26/2005
Three new genetic mutations in brain tumors identified
10/26/2005
Exploring Avastin`s effects on brain cancer
10/25/2005
BRAIN TUMOUR AWARENESS -
INTERNATIONAL LOGO COMPETITION KICKS OFF IN PARIS
10/23/2005
The Efficacy of Postoperative Ondansetron (Zofran®) Orally Disintegrating Tablets for Preventing Nausea and Vomiting After Acoustic Neuroma Surgery
10/20/2005
$10M grant aids cancer research
10/20/2005
Nanoparticles to target and treat brain tumors
10/20/2005
Celldex Announces Acquisition of Lorantis Limited and Assets of Alteris Therapeutics, Inc. (Note: Mentions brain tumor vaccine)
10/20/2005
Genentech in collaboration to explore Avastin for brain cancer treatment
10/20/2005
Light Sciences snags $35M in early stock offering
10/19/2005
virtualtrials.com will be out of service tonight
10/19/2005
Brain cancer patients fight an unseen enemy
Advice and updated information offered at recent area conference
10/19/2005
November 13th Brain Tumor Awareness Day: PurpleTrunk, The Brain Tumor Foundation and David Craig Welch Form an Alliance to Focus on Education, Early Detection and Fund Raising
10/19/2005
Oncolytics Biotech Inc. Ends Patient Treatment in Canadian Phase I Recurrent Malignant Glioma Clinical Trial
10/19/2005
NeoPharm Investigators Present Preliminary Phase I Data of Cintredekin Besudotox in the Treatment of Malignant Glioma at Initial Diagnosis
10/18/2005
Autumn Birth Linked to Childhood Brain Cancer
10/18/2005
O6–BG May Help Re-Sensitize Cancer Cells to Temodar® in Brain Cancer
which delivers brain tumor news and additions
to the website via RSS.